Abstract
Scottish 2010 guidelines for JIA-associated and idiopathic paediatric uveitis recommended disease-modifying anti-rheumatic drugs (DMARD) if there was initial posterior involvement or lack of uveitis control at 4 month review. We sought to examine which patients went on to require DMARDs and whether this was associated with posterior disease at presentation.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
